David Price appointed as Chief Financial Officer Concordia International

David Price has been appointed as CFO (Chief Financial Officer) of Concordia International. He will succeed Edward Borkowski and will be effective from May 15,2017. He will be reporting to company CEO Allan Oberman.

Mr. Price brings over 25 years of experience in the healthcare, investment banking and accounting industries. Most recently, he served as CFO of Bioventus Inc., EDGAR Online. Prior to EDGAR Online, Cornerstone Therapeutics, Inc. Previously he had served as MD in – Jefferies & Company in New York, and Bear Stearns & Co. in London and New York – and worked at PricewaterhouseCoopers Consulting and Arthur Andersen. He holds an honors degree in Accounting and Financial Management from Lancaster University in the UK and is a member of the Institute of Chartered Accountants in England and Wales.

Concordia CEO, Allan Oberman said that they are pleased to welcome David to their organization as CFO and believe that David’s wealth of experience managing global teams coupled with his broad expertise in financial management, business process improvement and operational excellence will be invaluable to Concordia as they work towards their goal of stabilizing the business and developing Concordia’s future growth strategy. David brings industry expertise and a unique perspective that they believe will enable Concordia to execute against the five key business priorities they outlined in March, and contribute to the development of their long-term growth strategy. On behalf of everyone at Concordia, He would like to extend their gratitude to Ed for his service to Concordia and wish him the best in his future endeavors.